Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
2019 ◽
Vol 7
(9)
◽
pp. 780-790
◽
2019 ◽
Vol 7
(9)
◽
pp. 727-728
◽
2014 ◽
Vol 203
(2)
◽
pp. W166-W173
◽